Lumizyme - 58468-0160-1 - (ALGLUCOSIDASE ALFA)

Alphabetical Index


Drug Information of Lumizyme

Product NDC: 58468-0160
Proprietary Name: Lumizyme
Non Proprietary Name: ALGLUCOSIDASE ALFA
Active Ingredient(s): 5    mg/mL & nbsp;   ALGLUCOSIDASE ALFA
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Lumizyme

Product NDC: 58468-0160
Labeler Name: Genzyme Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125291
Marketing Category: BLA
Start Marketing Date: 20100524

Package Information of Lumizyme

Package NDC: 58468-0160-1
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (58468-0160-1) > 10.5 mL in 1 VIAL, SINGLE-USE

NDC Information of Lumizyme

NDC Code 58468-0160-1
Proprietary Name Lumizyme
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (58468-0160-1) > 10.5 mL in 1 VIAL, SINGLE-USE
Product NDC 58468-0160
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ALGLUCOSIDASE ALFA
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20100524
Marketing Category Name BLA
Labeler Name Genzyme Corporation
Substance Name ALGLUCOSIDASE ALFA
Strength Number 5
Strength Unit mg/mL
Pharmaceutical Classes alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

Complete Information of Lumizyme


General Information